LDHA and neoplasm: A comparison was performed between a genetic approach (using shRNA for LDH-A knockdown (KD)) with a pharmacologic drug-targeted approach that inhibited LDH-A/B enzymatic activity (using GNE-R-140), in the GL261 and CT2A i.c. tumor models.